机构：[1]School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, 510006, PR China[2]The Second Clinical Medical College of Guangzhou University of Chinese Medicine/Post-Doctoral Research Station, Guangzhou, 510006, PR China广东省中医院[3]School of Chinese Medicine, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, PR China[4]College of Forestry and Landscape Architecture, South China Agricultural University, Guangzhou 510630, PR China
Oxyberberine (OBB), a main gut-mediated metabolite of Phellodendron chinense Cortex (PC), exhibits prominent protective property against acute liver injury (ALI). Heme oxygenase-1 (HO-1) is a vital molecule in attenuating acute and chronic liver injury for its prominent anti-oxidative injury and anti-inflammation properties. The present study was performed to investigate the hepatoprotective role of OBB through HO-1 signaling pathway in lipopolysaccharide/D-galactosamine (LPS/D-GalN) induced ALI. Our results indicated that PC treatment improved survival rate and its metabolite OBB evidently improved histopathological deteriorations and liver function. Additionally, OBB dramatically ameliorated hepatic oxidative stress and inflammation. Besides, OBB exerted remarkable HO-1 agonistic activity, even be comparable to hemin (a HO-1 inducer), as evidenced by increased HO-1 level, carbon monoxide and bilirubin activities, which are the markers of erythrocyte metabolism. Moreover, OBB modulated the parameters of inflammation and oxidative stress through HO-1 dependent pathway. Beyond this, OBB also notably suppressed the translocation of p65, enhanced antioxidation defense genes expressions, promoted the degradation of Kelch-like ECH-associated protein 1 (Keap1) and the nuclear translocation of nuclear factor-erythroid-2-related factor 2 (Nrf2). In conclusion, OBB could be the principle active meta-bolite substance of PC and exert excellent hepatoprotective effects via inducing HO-1 through coactivation of erythrocyte metabolism and Nrf2/HO-1 pathway.
基金：
Guangdong Basic and Applied Basic Research Foundation [2021B1515140003]; National Natural Science Foundation of China [82074082]; Guangdong Natural Science Foundation [2022A1515011706]
第一作者机构：[1]School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, 510006, PR China
通讯作者：
通讯机构：[1]School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, 510006, PR China[4]College of Forestry and Landscape Architecture, South China Agricultural University, Guangzhou 510630, PR China[*1]School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, PR China.[*2]College of Forestry and Landscape Architecture, South China Agricultural University, Guangzhou 510630, PR China.
推荐引用方式(GB/T 7714)：
Ai Gaoxiang,Wu Xiaoyan,Dou Yaoxing,et al.Oxyberberine, a novel HO-1 agonist, effectively ameliorates oxidative stress and inflammatory response in LPS/D-GalN induced acute liver injury mice via coactivating erythrocyte metabolism and Nrf2 signaling pathway[J].FOOD AND CHEMICAL TOXICOLOGY.2022,166:doi:10.1016/j.fct.2022.113215.
APA：
Ai, Gaoxiang,Wu, Xiaoyan,Dou, Yaoxing,Huang, Ronglei,Zhong, Linjiang...&Qu, Chang.(2022).Oxyberberine, a novel HO-1 agonist, effectively ameliorates oxidative stress and inflammatory response in LPS/D-GalN induced acute liver injury mice via coactivating erythrocyte metabolism and Nrf2 signaling pathway.FOOD AND CHEMICAL TOXICOLOGY,166,
MLA：
Ai, Gaoxiang,et al."Oxyberberine, a novel HO-1 agonist, effectively ameliorates oxidative stress and inflammatory response in LPS/D-GalN induced acute liver injury mice via coactivating erythrocyte metabolism and Nrf2 signaling pathway".FOOD AND CHEMICAL TOXICOLOGY 166.(2022)
医学